Scientists at McGill University in association with a University of the British Columbia research group presented the results of a very unusual study. For two years they have been trying to find a significant proof of medical benefits of cannabis. And finally they have found it. But the most interesting thing is that everyone can learn about this research, called COMPASS (“Cannabis for the Management of Pain: Assessment of Safety Study”), online in simple words. The COMPASS study was led by Dr Mark Ware, a famous doctor and scientist.
Dr. Ware is sure that the results of his project will definitely change the medicine. Furthermore, many doctors, who could not believe in medical marijuana a few months ago, now have completely changed their mind.
One of the COMPASS’ purposes was to discover efficient ways to fight chronic pain. That is why scientists decided to study long-term safety of medical cannabis—one of the most ancient natural painkillers. And they were more than surprised with results.
The participants of COMPASS were Canadians, that were drawn from different cities of the country. All of them were of different ages, genders, and jobs, but there was something that united them—a terrible chronic pain. Reasons for the pain were also different. So the research of Mark Ware gave them a second hope to enjoy life again. As in any study, there was a control group of patients who used traditional chemical anesthetics only.
The patients of the main group have been using medical cannabis along with their meds for one year. All that time the scientists of COMPASS have been monitoring their health closely in order to notice every negative or positive change. As a result, brave patients who used medical marijuana were no more likely to suffer any adverse events during their treatment.
This research once again brings into focus the issue of medical marijuana legalization. The COMPASS study helped scientists to document clinically a wide range of medical benefits of cannabis. Dr Ware’s project demonstrated how democratic medical research should look like. He is sure that sometimes federal barriers do not allow to broaden the mind and to find efficient alternative ways of treatment.
At the moment cannabis is considered as Schedule I drug as defined by the United States Controlled Substances Act. It is the most highly restricted classification. In fact, it is a federal felony in the U.S. to conduct scientific study of any substances classified as Schedule I.